Skip to content
  • How It Works
  • Peptides
  • FAQ
  • About
Log in
  • Facebook
  • Instagram
  • TikTok
MEDRe
  • How It Works
  • Peptides
  • FAQ
  • About
Log in COMING SOON
MEDRe
  • How It Works
  • Peptides
  • FAQ
  • About
COMING SOON

Item added to your cart

View cart

Notice of Privacy Practices (HIPAA)

MEDRe LLC

MEDRe LLC Notice of Privacy Practices (HIPAA)

Last Updated: June 17, 2026

THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.

I. Who We Are

This Notice of Privacy Practices (“Notice”) describes the privacy practices of MEDRe LLC, a Delaware limited liability company doing business as “MEDRe” (collectively “we,” “us,” or “MEDRe”). MEDRe operates as a technology storefront that connects customers seeking doctor-supervised wellness peptides with licensed physicians and 503A compounding pharmacies through our partner Ola Digital Health.

II. Our Privacy Obligations

We are required by law to maintain the privacy of your protected health information (“PHI”) and to provide you with this Notice of our legal duties and privacy practices with respect to your PHI. We are also obligated to notify you following a breach of unsecured PHI. When we use or disclose your PHI, we are required to abide by the terms of this Notice (or other notice in effect at the time of the use or disclosure).

III. Permissible Uses and Disclosures Without Your Written Authorization

We do not need your written authorization for the following uses and disclosures:

A. Treatment, Payment, and Health Care Operations

We may use and disclose your PHI (but not your “Highly Confidential Information” defined in Section IV.B) to facilitate treatment through licensed physicians via Ola Digital Health, obtain payment for services, and conduct health care operations such as quality assessment and improvement.

B. Disclosure to Relatives, Close Friends, and Other Caregivers

We may use or disclose your PHI to a family member, relative, close personal friend, or any other person you identify when you are present and do not object, or when we reasonably infer that you do not object.

C. Public Health Activities

We may disclose your PHI to public health authorities for purposes such as preventing or controlling disease, injury, or disability, or as otherwise authorized by law.

D. Victims of Abuse, Neglect, or Domestic Violence

We may disclose your PHI to a governmental authority authorized to receive reports of abuse, neglect, or domestic violence when we reasonably believe you are a victim.

E. Health Oversight Activities

We may disclose your PHI to health oversight agencies responsible for overseeing the health care system or compliance with government health programs.

F. Judicial and Administrative Proceedings

We may disclose your PHI in the course of a judicial or administrative proceeding in response to a lawful order or process.

G. Law Enforcement

We may disclose your PHI to law enforcement officials as required or permitted by law.

H. Decedents

We may disclose your PHI to a coroner, medical examiner, or funeral director as authorized by law.

I. Research

We may use or disclose your PHI for research purposes when an Institutional Review Board or Privacy Board approves a waiver of authorization.

J. Health or Safety

We may use or disclose your PHI to prevent or lessen a serious and imminent threat to a person’s or the public’s health or safety.

K. Specialized Government Functions

We may use and disclose your PHI to units of the government with special functions as authorized by law.

L. Workers’ Compensation

We may disclose your PHI as authorized by and to the extent necessary to comply with workers’ compensation or similar programs.

M. As Required by Law

We may use and disclose your PHI when required to do so by any other law not already referred to above.

IV. Uses and Disclosures Requiring Your Written Authorization

A. Use or Disclosure with Your Authorization

We must obtain your written authorization for uses and disclosures of PHI for marketing purposes, disclosures that constitute the sale of PHI, and any other uses and disclosures not described in this Notice.

B. Uses and Disclosures of Your Highly Confidential Information

Federal and state law requires special privacy protections for certain highly confidential information about you (“Highly Confidential Information”). We must obtain your written authorization to use or disclose Highly Confidential Information for purposes other than those permitted by law.

C. Revocation of Your Authorization

You may revoke your authorization at any time, except to the extent we have already acted in reliance upon it, by delivering a written statement to our Privacy Officer.

V. Your Rights Regarding Your Protected Health Information

A. For Further Information and Complaints

If you would like more information about your privacy rights, have concerns that we have violated your privacy rights, or disagree with a decision we made about access to your PHI, you may contact our Privacy Officer. You may also file written complaints with the Director, Office for Civil Rights of the U.S. Department of Health and Human Services. We will not retaliate against you for filing a complaint.

B. Right to Request Additional Restrictions

You have the right to request restrictions on the uses and disclosures of your PHI for treatment, payment, and health care operations, and to certain individuals involved in your care.

C. Right to Receive Confidential Communications

You may request, and we will accommodate, any reasonable written request to receive your PHI by alternative means of communication or at alternative locations.

D. Right to Inspect and Copy Your Health Information

You have the right to request access to inspect and obtain copies of your PHI. Requests for PHI are routed through Ola Digital Health. We may charge a reasonable, cost-based fee for copies.

E. Right to Request to Amend Your Records

You have the right to request that we (or Ola Digital Health on our behalf) amend your PHI. We will comply with your request unless we believe the information is accurate and complete or other special circumstances apply.

F. Right to Receive an Accounting of Disclosures

You have the right to request an accounting of certain disclosures of your PHI made by us (or on our behalf) during any period of time (not to exceed six years) prior to the date of your request.

G. Right to Receive a Copy of this Notice

You have the right to receive a paper or electronic copy of this Notice at any time.

VI. Effective Date and Duration of This Notice

A. Effective Date

This Notice is effective on June 10, 2026.

B. Right to Change Terms of this Notice

We may change the terms of this Notice at any time. If we change this Notice, we may make the new notice terms effective for all PHI that we maintain. If we change this Notice, we will post the new notice on our website at https://medre.org. You may also obtain any new notice by contacting us.

VII. Privacy Officer

MEDRe LLC

8 The Green, Suite B

Dover, DE 19901

support@medre.org

(302) 207-0669

MEDRe logo
support@medre.org (302) 207-0669
8 The Green, Suite B, Dover, DE 19901

The assessment made available on the MEDRe website does not create a doctor-patient relationship between the individual completing the assessment and MEDRe. MEDRe, a network of US-licensed physicians working through Ola Digital Health, adheres to rigorous medical protocols designed for patient safety. We have established exclusionary criteria to determine if an individual qualifies for doctor-supervised wellness peptides. The answers an individual provides to the MEDRe assessment consequently determine if the individual is screened out of eligibility, and an Ola Digital Health clinician will meet with the individual after intake to determine if they qualify for a prescription.

Ola Digital Health clinicians retain the decision to prescribe compounded doctor-supervised wellness peptides to patients.

All claims and benefits on this website refer to self-reported data from MEDRe customers on a treatment plan that includes compounded doctor-supervised wellness peptides and consultations with medical professionals. Customer-reported results on their initial medical intake questionnaire every 3–4 weeks thereafter. Results from compounded medications found on the MEDRe platform may vary and be affected by an individual's adherence to the program and their clinician's recommendations.

Compounded doctor-supervised wellness peptides are produced in FDA-regulated facilities. Although these facilities are highly regulated, the medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded drugs is guided by the licensed provider's medical judgment, which is informed by a telehealth consultation and medical history.

We encourage all prospective users of compounded doctor-supervised wellness peptides to speak with their provider about the specific risks and benefits that may come with the use of compounded doctor-supervised wellness peptides. MEDRe does not produce compounded doctor-supervised wellness peptides, and individuals may receive doctor-supervised wellness peptides that look different than what is portrayed on the website.


Pharmacy Providers

We are partnered with multiple USA-certified 503A compounding pharmacies to bring the best product and overall experience to our membership. Our team meets regularly with pharmacies to discuss any product shortages, shipping delays, and get updated reports on their medication testing.

Doctor-supervised wellness peptides are included in the cost of the MEDRe Program. All doctor-supervised wellness peptides are produced in FDA-regulated facilities.

Certain materials on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies. No representation or warranty is made regarding the accuracy, completeness, or reliability of such content. Individuals appearing in advertisements are or may be actors or models.

Testimonials on the website are from MEDRe patients. For patient privacy, images representing those testimonials may use models.

By accepting these Terms of Use, you additionally understand and agree that MEDRe is not acting as a pharmacy, nor does MEDRe control or interfere with any such services. By accepting these Terms of Use, you understand and agree that you may be entering into a relationship with a pharmacy, pharmacist, or pharmacy group or other such relationship with any one or more such third-party entities. Partner pharmacies include licensed 503A compounding pharmacies that fulfill doctor-supervised wellness peptide prescriptions.


MEDRe LLC

8 The Green, Suite B

Dover, DE 19901

support@medre.org

(302) 207-0669

© 2026 MEDRe. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • Privacy Practices
  • Refund Policy
  • Medical Consent
  • For California Residents
  • Bill of Rights

MEDRe

  • Choosing a selection results in a full page refresh.
  • Opens in a new window.